Retn (resistin) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Retn (resistin) Rattus norvegicus
Symbol: Retn
Name: resistin
RGD ID: 628781
Description: Predicted to enable hormone activity. Involved in several processes, including negative regulation of feeding behavior; positive regulation of cell communication; and positive regulation of smooth muscle cell proliferation. Located in extracellular space. Used to study colitis. Biomarker of metabolic dysfunction-associated steatotic liver disease. Human ortholog(s) of this gene implicated in hypertension; hypertrophic cardiomyopathy; obesity; and type 2 diabetes mellitus. Orthologous to human RETN (resistin); INTERACTS WITH (S)-nicotine; 1,2-dimethylhydrazine; 1-methylnicotinamide.
Type: protein-coding
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2121,710,881 - 1,712,621 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl121,710,881 - 1,712,620 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx122,377,668 - 2,379,407 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0123,001,238 - 3,002,977 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0121,772,202 - 1,773,941 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0122,201,909 - 2,203,649 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl122,201,891 - 2,204,249 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0124,364,007 - 4,365,747 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4122,499,630 - 2,501,370 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1122,499,629 - 2,501,370 (-)NCBI
Celera123,566,836 - 3,568,576 (+)NCBICelera
Cytogenetic Map12p12NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(1->4)-beta-D-glucan  (ISO)
(S)-nicotine  (EXP)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (EXP)
1-methylnicotinamide  (EXP)
17beta-estradiol  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2-trans,6-trans,10-trans-geranylgeranyl diphosphate  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,4-methylenedioxymethamphetamine  (ISO)
3,7-dihydropurine-6-thione  (EXP)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
9-cis-retinoic acid  (ISO)
aflatoxin B1  (ISO)
aldehydo-D-glucose  (ISO)
all-trans-retinoic acid  (ISO)
all-trans-retinol  (ISO)
Aloe emodin  (ISO)
alpha-melanocyte stimulating hormone  (ISO)
amlodipine  (ISO)
ammonium chloride  (EXP)
amphetamine  (EXP)
arachidonic acid  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
Aurothioglucose  (ISO)
benzo[a]pyrene  (ISO)
benzo[b]fluoranthene  (ISO)
benzofurans  (ISO)
bis(2-chloroethyl) sulfide  (EXP)
bisphenol A  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
cannabidiol  (ISO)
cantharidin  (ISO)
capsaicin  (EXP)
carbon nanotube  (ISO)
choline  (ISO)
corticosterone  (ISO)
D-glucose  (ISO)
deoxycholic acid  (ISO)
dexamethasone  (ISO)
diarsenic trioxide  (ISO)
disodium cromoglycate  (ISO)
fenofibrate  (ISO)
folic acid  (ISO)
fructose  (EXP,ISO)
fucoxanthin  (ISO)
fulvestrant  (ISO)
genistein  (ISO)
glucose  (ISO)
glycine  (ISO)
herbicide  (ISO)
hesperetin  (ISO)
hydrazine  (ISO)
hydrazines  (ISO)
Indeno[1,2,3-cd]pyrene  (ISO)
iron atom  (ISO)
iron(0)  (ISO)
L-methionine  (ISO)
letrozole  (EXP)
lipopolysaccharide  (ISO)
mercaptopurine  (EXP)
metformin  (EXP)
mevalonic acid  (ISO)
monosodium L-glutamate  (ISO)
naproxen  (EXP,ISO)
nicotine  (EXP)
nicotinic acid  (ISO)
nitric oxide  (EXP,ISO)
nitroprusside  (ISO)
NMN zwitterion  (ISO)
Nonylphenol  (ISO)
oxybenzone  (EXP)
ozone  (EXP,ISO)
perfluorodecanoic acid  (ISO)
perfluorononanoic acid  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
perfluoroundecanoic acid  (ISO)
phenethyl caffeate  (ISO)
phosphatidylcholine  (ISO)
picolinic acid  (ISO)
pioglitazone  (ISO)
potassium bromate  (EXP)
progesterone  (EXP,ISO)
prostaglandin E2  (ISO)
protein kinase inhibitor  (ISO)
purine-6-thiol  (EXP)
resveratrol  (EXP,ISO)
SB 203580  (ISO)
simvastatin  (ISO)
stilben-4-ol  (ISO)
streptozocin  (EXP)
sulforaphane  (ISO)
sumatriptan  (EXP)
testosterone  (ISO)
titanium dioxide  (ISO)
tributylstannane  (ISO)
triptonide  (ISO)
triticonazole  (EXP)
vinclozolin  (EXP)
XL147  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function


References - curated
# Reference Title Reference Citation
1. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification. Baker JF, etal., J Rheumatol. 2011 Nov;38(11):2369-75. doi: 10.3899/jrheum.110237. Epub 2011 Sep 1.
2. Resistin level in coronary artery disease and heart failure: the central role of kidney function. Baldasseroni S, etal., J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):150-7. doi: 10.2459/JCM.0b013e32834eec93.
3. Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Chi S, etal., Mol Cell Biochem. 2009 Apr 21.
4. Low resistin level is associated with poor hospitalization-free survival in hemodialysis patients. Chung W, etal., J Korean Med Sci. 2012 Apr;27(4):377-81. doi: 10.3346/jkms.2012.27.4.377. Epub 2012 Mar 21.
5. Possible common central pathway for resistin and insulin in regulating food intake. Cifani C, etal., Acta Physiol (Oxf). 2009 Aug;196(4):395-400. doi: 10.1111/j.1748-1716.2008.01949.x. Epub 2008 Dec 16.
6. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis. Clemente TR, etal., Scand J Gastroenterol. 2012 Sep;8-9(47):943-50. doi: 10.3109/00365521.2012.688213. Epub 2012 May 28.
7. Alternative splicing generates a novel non-secretable resistin isoform in Wistar rats. Del Arco A, etal., FEBS Lett. 2003 Dec 4;555(2):243-9.
8. Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats. Delhanty PJ, etal., Endocrinology 2002 Jun;143(6):2445-8.
9. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Diez JJ, etal., Clin Endocrinol (Oxf). 2005 Feb;62(2):242-9.
10. Inverse association between serum resistin and insulin resistance in humans. Dominguez Coello S, etal., Diabetes Res Clin Pract. 2008 Nov;82(2):256-61. Epub 2008 Sep 11.
11. The expression of rat resistin isoforms is differentially regulated in visceral adipose tissues: effects of aging and food restriction. Fernandez CM, etal., Metabolism. 2009 Feb;58(2):204-11. doi: 10.1016/j.metabol.2008.09.014.
12. Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Fraser DD, etal., Crit Care Explor. 2020 Jun 22;2(6):e0144. doi: 10.1097/CCE.0000000000000144. eCollection 2020 Jun.
13. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
14. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
15. Resistin promotes 3T3-L1 preadipocyte differentiation. Gong H, etal., Eur J Endocrinol. 2004 Jun;150(6):885-92.
16. Impact of uremia on human adipose tissue phenotype. Ho KJ, etal., J Surg Res. 2013 Jan;179(1):175-82. doi: 10.1016/j.jss.2012.08.043. Epub 2012 Sep 6.
17. Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients. Hussain S, etal., Transl Res. 2010 Mar;155(3):142-7. doi: 10.1016/j.trsl.2009.10.002. Epub 2009 Nov 4.
18. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Koch A, etal., Crit Care. 2009;13(3):R95. doi: 10.1186/cc7925. Epub 2009 Jun 19.
19. Central resistin enhances renal sympathetic nerve activity via phosphatidylinositol 3-kinase but reduces the activity to brown adipose tissue via extracellular signal-regulated kinase 1/2. Kosari S, etal., J Neuroendocrinol. 2012 Nov;24(11):1432-9. doi: 10.1111/j.1365-2826.2012.02352.x.
20. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. Kreier F, etal., J Clin Invest 2002 Nov;110(9):1243-50.
21. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Kuzmicki M, etal., Gynecol Endocrinol. 2009 Apr;25(4):258-63.2: id: 38815448 Error occurred: The following PMID is not available: -13: id: 58220487 Error occurred: The following PMID is not available: -14: id: 77618179 Error occurred: The following PMID is not available: -1
22. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Lee SH, etal., Coron Artery Dis. 2009 Jan;20(1):33-9. doi: 10.1097/MCA.0b013e328318ecb0.
23. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. Lu SC, etal., FEBS Lett 2002 Oct 23;530(1-3):158-62.
24. Expression and effect of resistin on bovine and rat granulosa cell steroidogenesis and proliferation. Maillard V, etal., Reproduction. 2011 Apr;141(4):467-79. doi: 10.1530/REP-10-0419. Epub 2011 Jan 14.
25. A Pilot Study Suggests that the G/G Genotype of Resistin Single Nucleotide Polymorphism at -420 May Be an Independent Predictor of a Reduction in Fasting Plasma Glucose and Insulin Resistance by Pioglitazone in Type 2 Diabetes. Makino H, etal., Endocr J. 2009 Sep 9.
26. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Malyszko J, etal., Transplant Proc. 2006 Dec;38(10):3434-6.
27. Hyperresistinemia - a novel feature in systemic infection during human pregnancy. Mazaki-Tovi S, etal., Am J Reprod Immunol. 2010 May;63(5):358-69. doi: 10.1111/j.1600-0897.2010.00809.x. Epub 2010 Feb 18.
28. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
29. Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. Nehus E, etal., J Pediatr. 2012 Aug;161(2):276-80. doi: 10.1016/j.jpeds.2012.01.055. Epub 2012 Mar 14.
30. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. Norata GD, etal., J Intern Med. 2007 Jul;262(1):104-12.
31. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
32. Online Mendelian Inheritance in Man, OMIM (TM). Online Mendelian Inheritance in Man, OMIM (TM).
33. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes. Osawa H, etal., Biochem Biophys Res Commun. 2007 Apr 6;355(2):342-6. Epub 2007 Feb 5.
34. [The significance of resistin concentration in metabolical diseases]. Rasic D, etal., Vojnosanit Pregl. 2010 Dec;67(12):965-8.
35. GOA pipeline RGD automated data pipeline
36. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
37. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
38. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Roth CL, etal., Hepatology. 2012 Apr;55(4):1103-11. doi: 10.1002/hep.24737. Epub 2012 Feb 15.
39. Over expression of resistin in adipose tissue of the obese induces insulin resistance. Sadashiv, etal., World J Diabetes. 2012 Jul 15;3(7):135-41. doi: 10.4239/wjd.v3.i7.135.
40. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Schaffler A, etal., Horm Metab Res. 2004 Oct;36(10):702-7.
41. Resistin contributes to neointimal formation via oxidative stress after vascular injury. Shyu KG, etal., Clin Sci (Lond). 2011 Feb;120(3):121-9. doi: 10.1042/CS20100226.
42. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. Smalley DM, etal., J Proteome Res. 2008 May;7(5):2088-96. doi: 10.1021/pr700775x. Epub 2008 Mar 29.
43. The hormone resistin links obesity to diabetes. Steppan CM, etal., Nature. 2001 Jan 18;409(6818):307-12.
44. The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. Suriyaprom K, etal., J Clin Biochem Nutr. 2009 Jan;44(1):104-10. Epub 2008 Dec 27.
45. Association of resistin gene 3'-untranslated region +62G-->A polymorphism with type 2 diabetes and hypertension in a Chinese population. Tan MS, etal., J Clin Endocrinol Metab. 2003 Mar;88(3):1258-63.
46. Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypertension. Tsioufis C, etal., Am J Hypertens. 2010 Jun;23(6):681-6. doi: 10.1038/ajh.2010.34. Epub 2010 Mar 4.
47. Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Tsukahara T, etal., Diabetes Res Clin Pract. 2009 May;84(2):179-86. Epub 2009 Mar 6.
48. Regulation of resistin by cyclic mechanical stretch in cultured rat vascular smooth muscle cells. Wang BW, etal., Clin Sci (Lond). 2009 Oct 26;118(3):221-30.
49. [The relationship between resistin and the peripheral neuropathy in type 2 diabetes]. Wang XH, etal., Zhonghua Yi Xue Za Zhi. 2007 Jul 3;87(25):1755-7.
50. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats. Yang G, etal., Metabolism. 2005 Sep;54(9):1142-6.
51. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. Zhao J, etal., Scand J Gastroenterol. 2010 Nov;45(11):1360-71. doi: 10.3109/00365521.2010.497938. Epub 2010 Jun 21.
Additional References at PubMed
PMID:11209052   PMID:12429872   PMID:12477932   PMID:12634438   PMID:12660872   PMID:12885401   PMID:12944409   PMID:14577616   PMID:14592417   PMID:15226398   PMID:15526156   PMID:15642357  
PMID:15737463   PMID:16154759   PMID:16338222   PMID:16404608   PMID:16934751   PMID:17063326   PMID:17241525   PMID:17418807   PMID:17557231   PMID:17573461   PMID:17611902   PMID:17693256  
PMID:17890220   PMID:17922337   PMID:17991727   PMID:18063850   PMID:18176969   PMID:18178314   PMID:18239591   PMID:18499762   PMID:18597775   PMID:19008713   PMID:19041881   PMID:19589870  
PMID:19785957   PMID:20627112   PMID:21478152   PMID:21557150   PMID:21586564   PMID:22372349   PMID:22645452   PMID:22855443   PMID:23376485   PMID:23533145   PMID:23765438   PMID:23867317  
PMID:23901222   PMID:24610624   PMID:25065280   PMID:25217974   PMID:26383117   PMID:26811539   PMID:26846568   PMID:26909974   PMID:27797297   PMID:27959400   PMID:28877872   PMID:29500410  
PMID:30612469   PMID:31053755   PMID:31085594   PMID:32410876  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2121,710,881 - 1,712,621 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl121,710,881 - 1,712,620 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx122,377,668 - 2,379,407 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0123,001,238 - 3,002,977 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0121,772,202 - 1,773,941 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0122,201,909 - 2,203,649 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl122,201,891 - 2,204,249 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0124,364,007 - 4,365,747 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4122,499,630 - 2,501,370 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1122,499,629 - 2,501,370 (-)NCBI
Celera123,566,836 - 3,568,576 (+)NCBICelera
Cytogenetic Map12p12NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38197,669,049 - 7,670,455 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl197,669,049 - 7,670,455 (+)EnsemblGRCh38hg38GRCh38
GRCh37197,733,935 - 7,735,341 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36197,639,972 - 7,641,340 (+)NCBINCBI36Build 36hg18NCBI36
Build 34197,639,971 - 7,641,340NCBI
Celera197,605,160 - 7,606,528 (+)NCBICelera
Cytogenetic Map19p13.2NCBI
HuRef197,403,771 - 7,405,139 (+)NCBIHuRef
CHM1_1197,733,708 - 7,735,063 (+)NCBICHM1_1
T2T-CHM13v2.0197,669,929 - 7,671,334 (+)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm3983,705,770 - 3,709,818 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl83,705,770 - 3,710,110 (+)EnsemblGRCm39 Ensembl
GRCm3883,655,770 - 3,659,818 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl83,655,770 - 3,660,110 (+)EnsemblGRCm38mm10GRCm38
MGSCv3783,655,789 - 3,658,096 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv3683,655,789 - 3,658,096 (+)NCBIMGSCv36mm8
Celera83,886,118 - 3,888,425 (+)NCBICelera
Cytogenetic Map8A1.1NCBI
cM Map81.92NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049555631,607,814 - 1,609,273 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049555631,607,814 - 1,609,273 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan11911,457,254 - 11,458,754 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0196,958,536 - 6,960,032 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1197,812,942 - 7,814,909 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl197,812,942 - 7,814,909 (+)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.12052,434,148 - 52,435,627 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2052,434,271 - 52,435,624 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha2052,238,221 - 52,239,712 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.02052,963,476 - 52,964,967 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2052,963,614 - 52,964,967 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12052,167,243 - 52,168,734 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02052,610,828 - 52,612,319 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.02052,842,073 - 52,843,564 (+)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_024405118213,128,130 - 213,129,482 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365884,705,119 - 4,706,656 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365884,705,295 - 4,706,653 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl271,484,169 - 71,485,616 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1271,484,164 - 71,485,577 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2271,871,237 - 71,872,650 (+)NCBISscrofa10.2Sscrofa10.2susScr3
Pig Cytomap2q21NCBI
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.167,154,771 - 7,156,459 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl67,155,337 - 7,156,505 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_023666081704,895 - 706,306 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_004624828735,503 - 737,166 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624828735,562 - 737,166 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Retn
6 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:131
Count of miRNA genes:108
Interacting mature miRNAs:117
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1300174Bw15Body weight QTL 152.93body mass (VT:0001259)body weight loss (CMO:0001399)1219318387Rat
2312418Kidm41Kidney mass QTL 413.70.0001kidney mass (VT:0002707)single kidney wet weight to body weight ratio (CMO:0000622)12119611090Rat
10755457Coatc14Coat color QTL 140.01759coat/hair pigmentation trait (VT:0010463)pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812)12122591684Rat
6893681Bw109Body weight QTL 1092.30.004body mass (VT:0001259)body weight (CMO:0000012)12123297788Rat
1581516Cm56Cardiac mass QTL 564.20.05heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)12129333307Rat
1598855Bp294Blood pressure QTL 2943.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)12134851688Rat
7411660Foco28Food consumption QTL 2810.90.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)12142110980Rat
9590086Insglur6Insulin/glucose ratio QTL 618.970.001blood insulin amount (VT:0001560)calculated plasma insulin level (CMO:0002170)12142110980Rat
8694179Bw150Body weight QTL 1502.90.001body mass (VT:0001259)body weight gain (CMO:0000420)12142110980Rat
7411586Foco5Food consumption QTL 55.40.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)12142110980Rat
7411595Foco9Food consumption QTL 940.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)12142110980Rat
7411545Bw128Body weight QTL 1285.20.001body mass (VT:0001259)body weight gain (CMO:0000420)12142110980Rat
9590147Scort7Serum corticosterone level QTL 713.610.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)12142110980Rat
2303575Insul14Insulin level QTL 144blood insulin amount (VT:0001560)blood insulin level (CMO:0000349)12142450532Rat
737979Pia22Pristane induced arthritis QTL 2253.1joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)12144465750Rat
634351Apr5Acute phase response QTL 56.7blood interleukin-6 amount (VT:0008595)plasma interleukin-6 level (CMO:0001927)12144503507Rat
2302042Pia38Pristane induced arthritis QTL 383.50.001blood immunoglobulin amount (VT:0002460)serum immunoglobulin G1 level (CMO:0002115)12144503507Rat
7243862Mcs30Mammary carcinoma susceptibility QTL 308.62mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)127977298525593Rat
634350Apr4Acute phase response QTL 46orosomucoid 1 amount (VT:0010541)plasma orosomucoid 1 level (CMO:0001467)12117200546172005Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2121,712,810 - 1,713,029 (+)MAPPERmRatBN7.2
Rnor_6.0122,203,839 - 2,204,057NCBIRnor6.0
Rnor_5.0124,365,937 - 4,366,155UniSTSRnor5.0
RGSC_v3.4122,499,222 - 2,499,440UniSTSRGSC3.4
Celera123,568,766 - 3,568,984UniSTS
Cytogenetic Map12p12UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 13 2 4 2 1 6 2
Low 3 12 21 16 7 16 7 10 19 3 9 7
Below cutoff 6 11 11 8 11 1 1 10 10 14 1


RefSeq Acc Id: ENSRNOT00000001325   ⟹   ENSRNOP00000001325
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl121,710,881 - 1,712,620 (+)Ensembl
Rnor_6.0 Ensembl122,201,949 - 2,203,614 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000091197   ⟹   ENSRNOP00000073327
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl122,201,891 - 2,204,249 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000096056   ⟹   ENSRNOP00000096426
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl121,710,882 - 1,712,620 (+)Ensembl
RefSeq Acc Id: NM_144741   ⟹   NP_653342
Rat AssemblyChrPosition (strand)Source
mRatBN7.2121,710,881 - 1,712,621 (+)NCBI
Rnor_6.0122,201,909 - 2,203,649 (+)NCBI
Rnor_5.0124,364,007 - 4,365,747 (+)NCBI
RGSC_v3.4122,499,630 - 2,501,370 (-)RGD
Celera123,566,836 - 3,568,576 (+)RGD
RefSeq Acc Id: NP_653342   ⟸   NM_144741
- Peptide Label: precursor
- UniProtKB: Q8K4J7 (UniProtKB/TrEMBL),   F7EKN8 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000073327   ⟸   ENSRNOT00000091197
RefSeq Acc Id: ENSRNOP00000001325   ⟸   ENSRNOT00000001325
RefSeq Acc Id: ENSRNOP00000096426   ⟸   ENSRNOT00000096056

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q8K4J7-F1-model_v2 AlphaFold Q8K4J7 1-114 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13698374
Promoter ID:EPDNEW_R8899
Type:single initiation site
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database,
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.0122,201,936 - 2,201,996EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:628781 AgrOrtholog
BioCyc Gene G2FUF-20385 BioCyc
Ensembl Genes ENSRNOG00000001001 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000001325 ENTREZGENE
  ENSRNOT00000001325.6 UniProtKB/TrEMBL
  ENSRNOT00000096056.1 UniProtKB/TrEMBL
InterPro Resistin UniProtKB/TrEMBL
  Resistin-like_sf UniProtKB/TrEMBL
KEGG Report rno:246250 UniProtKB/TrEMBL
Pfam Resistin UniProtKB/TrEMBL
PhenoGen Retn PhenoGen
RatGTEx ENSRNOG00000001001 RatGTEx
Superfamily-SCOP Resistin UniProtKB/TrEMBL
UniProt A0A8I6B465_RAT UniProtKB/TrEMBL
  Q70Q42_RAT UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2004-09-10 Retn  resistin      Symbol and Name status set to approved 1299863 APPROVED
2003-02-27 Retn  resistin      Symbol and Name status set to provisional 70820 PROVISIONAL

RGD Curation Notes
Note Type Note Reference
gene_expression expressed in white adipose tissue 633881
gene_expression expressed in the adipose tissues 628347
gene_expression expression is induced by growth hormone in the spontaneous dwarf strain 633881
gene_regulation expression of mRNA is decreased by a fat pad specific vagotomy 628347